Search
Spero Therapeutics Inc
SPROAdd to Watchlist
1.120USD
-0.050-4.27%
Close 09-10 16:00（ET）
65.42MMarket Cap
4.05P/E TTM
After-hours (ET)0.000USD0.000
After-hours (ET)Spero Therapeutics Inc (SPRO) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Spero Therapeutics Inc in the past month.
Hold
0 Strong Buy
0 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
4.000USD+230.58%
SPRO Analyst Recommendation Trends
In the current month, SPRO has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SPRO average Analyst price target in the last month is 4.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
SPRO Analyst Rating for Peer Comparison
Updated: Sep 10, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
Biontech SE
BNTX
4
13
5
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, SPRO EPS is projected to reach -0.160 in FY2026Q3, following reported EPS of -0.165 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
Forecast
-0.20
-0.18
-0.17
-0.16
Actual
0.56
-0.13
-0.16
--
Surprise
+379.03%
+30.14%
+3.07%
--
FAQs
What is Spero Therapeutics Inc's price target?
Analysts forecast that Spero Therapeutics Inc's price target is USD 4.00, with the highest forecast at USD 4.00 and the lowest forecast at USD 4.00.
How have Spero Therapeutics IncSPRO's recent earnings per share performed?
The market expectation was USD -0.16, while Spero Therapeutics IncSPRO's earnings per share (EPS) for the previous quarter was USD -0.13. EPS for the next quarter is expected at USD -0.16.
What is the analyst rating for Spero Therapeutics Inc?
Based on the ratings of Spero Therapeutics Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.